COVID-19 Information for Sponsored Programs

During COVID-19, the Office of Sponsored Programs (OSP) plans to be fully operational.

The Office of Sponsored Programs (OSP) is currently fully operational. In response to the COVID-19 Pandemic, OSP will be working from home beginning March 16, 2020 until further notice. OSP staff continue to be available by email and phone, and our main line (412-624-7400) can also be used. Transaction requests and their related communications should continue to be sent through OSP electronic systems (MyFunding, MyRA, Contraxx, etc.)

For the latest updates from PittResearch, visit https://research.pitt.edu/pitt-researchers/research-operations-during-covid-19-pandemic. For all updates related to the University’s response to the COVID-19 pandemic, please visit www.emergency.pitt.edu/covid-19.

This page was last updated 05/16/2022 10:30 AM

 

OSP is monitoring the release of information related to COVID-19 from the University of Pittsburgh and from funding sponsors, including federal agencies. The information below will continue to be updated.

OSP Communications
E-mail regarding COVID-19 Information (released 03-12-2020) 

Pitt Research

Senior Vice Chancellor for Research Update on Research at Pitt (12-14-2020)
Office of Research Protections Important Update on Tier 3 Studies (11-24-2020)
​Senior Vice Chancellor for Research Update on Tier 3 Research Activities (11-23-2020)
Senior Vice Chancellor for Research Updated Details, Resources for Research Operations During the Pandemic (10-20-2020)
Senior Vice Chancellor for Research Research Restart website (06-10-2020)
Senior Vice Chancellor for Research Research Restart announcement (06-03-2020)
Senior Vice Chancellor for Research Guidelines for Essential Research Personnel  (released 03-25-2020)
Senior Vice Chancellor for Research Coordination of COVID-19 Research at Pitt and UPMC (released 03-23-2020)
Senior Vice Chancellor for Research COVID-19: Status of Clinical Research Operations at Pitt (released 03-16-2020)
Senior Vice Chancellor for Research Pandemic Preparedness Guide for Researchers (released 03-12-2020)
Senior Vice Chancellor for Research Important - Clinical Research operations and COVID-19 (released 03-11-2020)
Senior Vice Chancellor for Research Emergency Page (released 03-11-2020) 
Senior Vice Chancellor for Research COVID-19: Status of Research Operations at Pitt (released 03-11-2020)

University of Pittsburgh
Office of the Chancellor Our plans for being safe on campus (released 06-20-2020)
COVID-19 Update, confirmed case of coronavirus on campus (released 03-22-2020)
Office of Human Resources COVID-19 Workplace Concerns: Resources for Employees (released 03-18-2020)
​Office of the Chancellor A Reduction in Operating Status (released 03-18-2020)
Office of the Chancellor COVID-19 update for faculty and staff (released 03-14-2020)
Office of the Chancellor COVID-19 Pandemic: Pitt's Actions (released 03-10-2020)
Pitt OHR Information Regarding Travel Expense Reimbursement and COVID-19 (released 03-10-2020) 
Public Safety & Emergency Management’s COVID-19 information page (released 03-10-2020)
Pitt IT's Covid-19 Preparation Information (released 03-10-2020)

External Agencies

Funding Opportunities

Agency
Opportunity ID
Sponsor Due Date Posted
Cisco RFP-20-04 Pandemic/COVID19 Science, Technology and Social Impact Rolling 07-19-2020
Department of Health and Human Services RFA-IP-22-004 US Platform to Measure Effectiveness of Seasonal Influenza, COVID-19 and other Respiratory Virus Vaccines for the Prevention of Acute Illness in Ambulatory Settings 02-01-2022 08-02-2021
Department of Labor Employment and Training Administration ETA-TEGL-12-19 National Dislocated Worker Grants Program  Rolling 03-19-2020
Fast Grants Emergent Ventures: Fast Funding for COVID-19 Science Rolling/Ongoing 04-08-2020
National Center for Advancing Translational Sciences (NCATS) NOT-TR-21-017 Notice of Special Interest (NOSI): Administrative Supplements for the Clinical and Translational Science Award (CTSA) Program to Address COVID-19 Public Health Needs Rolling through 08-16-2024 02-05-2021
National Institute on Alcohol Abuse and Alcoholism (NIAAA) NOT-AA-22-012 Notice of Special Interest: Research on Alcohol and Coronavirus Disease (COVID-19) within the Mission of NIAAA 03-05-2024 05-02-2022
National Institute of Allergy and Infectious Diseases (NIAID) PAR-21-276 Limited Competition Emergency Awards: Shared Personal Protective Equipment Resources for COVID-19 Related Vaccine and Treatment Clinical Trials and Clinical Studies (S10 Clinical Trial Not Allowed) Rolling 07-19-2021
National Institute of Allergy and Infectious Diseases (NIAID) NOT-AI-21-061 Notice to Extend Eligibility for Submission of K99/R00 Pathway to Independence Award Applications (and Physician-Scientist K99/R00) due to COVID–related Disruptions Various through July 2022 07-02-2021
National Institute of Biomedical Imaging and Biomedical Engineering NIH POCTRN Fast-Track Program for COVID-19 Test Development and Distribution Rolling 05-15-2020
National Institute of Environmental Health Sciences NOT-ES-22-002 Notice of NIEHS Participation on PAR-22-048 "Clinical Relevance of the Linkage between Environmental Toxicant Exposures and Alzheimer’s Disease and Related Dementias (R01 Clinical Trial Not Allowed)" 03-11-2022  11-01-2021
National Institute of Child Health and Human Development (NICHD) NOT-HD-21-037 Notice of Special Interest (NOSI): Competitive Revision and Administrative Supplements to Existing NICHD HIV Grants and Cooperative Agreements to Understand HIV Health Impacts of COVID-19 
AIDS Application Due Date(s) – May 7, 2022, by 5:00 PM local time of applicant organization. Applications received after the designated receipt dates will not be considered.
Various 07-02-2021
National Institute of Child Health and Human Development (NICHD) NOT-HD-21-026 Notice of Special Interest (NOSI): Research on the Impact of the Covid 19 Pandemic and Risks for Abuse and Injury Among Vulnerable Children and Youth 05-08-2024 05-03-2021
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) NOT-DK-22-017 Notice of Special Interest (NOSI): Availability of Urgent Competitive Revisions for Epidemiologic Studies of Diabetes Incidence and Severity and Its Potential Association with COVID-19 06-01-2022 04-04-2022
National Institute on Drug Abuse (NIDA) NOT-DA-21-041 Notice of Special Interest (NOSI) Announcing the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus 03-31-2022 04-19-2021
National Institute on Drug Abuse (NIDA) NOT-DA-21-017 Notice of Special Interest (NOSI): Medical Consequences of Smoking and Vaping Drugs of Abuse in Individuals with HIV and COVID-19
This notice applies to due dates on or after May 5, 2021 and subsequent receipt dates through September 7, 2024. 
See text 02-08-2021
National Institute on Drug Abuse (NIDA) NOT-DA-21-018 Notice of Special Interest (NOSI): Long-Term Neurocognitive Consequences of COVID-19 in Individuals Living with HIV and Substance Use Disorders
This notice applies to due dates on or after May 7, 2021 and subsequent receipt dates through September 7, 2024
See text 02-05-2021
National Institute of Environmental Health Sciences (NIEHS) NOT-ES-22-005 Notice of Special Interest (NOSI): Promoting Health, Safety, and Recovery Training for COVID-19 Essential Workers and their Communities 06-06-2022 04-04-2022
National Institute of Mental Health (NIMH) NOT-MH-21-225 Notice of Special Interest (NOSI): COVID-19 Related School Disruptions Impact on Mental Health, Cognitive, Social, and Emotional Development of Children 09-08-2022 04-05-2021
National Institute of Neurological Disorders and Stroke NOT-NS-20-074 Notice of Change to Eligible Activity Codes for NOT-NS-20-051 "Notice of Special Interest: Availability of Urgent Competitive Revisions and Administrative Supplements For Research on Biological Effects of the 2019 Novel Coronavirus on the Nervous System" N/A 05-27-2020
National Institute on Deafness and Other Communication Disorders (NIDCD) NOT-DC-20-006 Notice of Eligibility Change for NIDCD Urgent Competitive Revisions and Administrative Supplements for Research on COVID-19 N/A 04-22-2020
NIH NOT-HD-22-003 Notice of Special Interest (NOSI) - Administrative Supplements for Research of Emerging and Existing Issues of COVID-19 Related to the Health and Well-Being of Women, Children and Individuals with Physical and/or Intellectual Disabilities 06-06-2024 04-22-2022
NIH NOT-HD-22-002 Notice of Special Interest (NOSI) - Emerging and Existing Issues of Coronavirus Disease 2019 (COVID-19) Research Related to the Health and Well-Being of Women, Children and Individuals with Physical and/or Intellectual Disabilities 06-06-2024 04-04-2022
NIH RFA-NR-22-001 Evaluating the Impact of COVID-19 Pandemic-related Food and Housing Policies and Programs on Health Outcomes in Health Disparity Populations (R01 Clinical Trial Optional) 03-07-2022 0`-25-2022
NIH PAR-21-275 The Role of Work in Health Disparities in the U.S. (R01 Clinical Trials Optional) varies 06-28-2021
NIH PA-21-232 Comprehensive Care for Adults with Type 2 Diabetes Mellitus from Populations with Health Disparities (R01 Clinical Trial Optional) Various, see notice 05-28-2021
NIH NOT-OD-21-125 Notice of Correction to NOT-OD-21-103, "Notice of Special Interest (NOSI): Emergency Competitive Revisions for Community-engaged COVID-19 Testing Interventions among Underserved and Vulnerable Populations – RADx-UP Phase II (Emergency Supplement - Clinical Trial Optional)   05-18-2021
NIH NOT-HD-21-026 Notice of Special Interest (NOSI): Research on the Impact of the Covid 19 Pandemic and Risks for Abuse and Injury Among Vulnerable Children and Youth 05-31-2024 04-27-2021
NIH NOT-OD-21-106 Continuation of Temporary Extension of Eligibility for the NIH K99/R00 Pathway to Independence Award During the COVID-19 Pandemic Varies through July 2022 04-19-2021
NIH NOT-MH-21-225 Notice of Special Interest (NOSI): COVID-19 Related School Disruptions Impact on Mental Health, Cognitive, Social, and Emotional Development of Children N/A 03-31-2021
NIH NOT-OD-21-052 Reminder – Requesting Extensions for Early Career Scientists Whose Career Trajectories Have Been Significantly Impacted by COVID-19   02-08-2021
NIH NOT-DA-21-011 Notice of Special Interest (NOSI): Effects of smoking and vaping on the risk and outcome of COVID-19 infection 09-08-2024 01-26-2021
NIH NOT-DE-21-001 Notice of Special Interest (NOSI): NIDCR Support for Research on the Physiological Involvement of Oral Cavity in Coronavirus Disease 2019 (COVID-19) This notice applies to due dates on or after June 5, 2021 and subsequent receipt dates through May 8, 2023. 05-08-2023 01-26-2021
NIH NOT-HD-20-031 Notice of Special Interest (NOSI) – Research on Rehabilitation Needs Associated with the COVID-19 Pandemic 05-08-2023 10-02-2020
NIH NOT-OD-20-179 Extending the Special Exception to the NIH/AHRQ/NIOSH Post-Submission Material Policy During the COVID-19 Pandemic: August/October 2021 Councils 30 days prior to session date 10-02-2020
NIH PAR-20-312 State Occupational Safety and Health Surveillance Program (U60)
Letter of Intent Due Date(s): 10-20-2020, 08-10-2021, 8-10-2022
Application Due Date(s): 12-16-2020, 09-14-2021, 09-14-2022
See Text 09-29-2020
NIH NOT-HS-20-007 Notice of Intent: Revision Supplements to Existing AHRQ Grants and Cooperative Agreements to Address Health System Responsiveness to COVID-19  N/A 03-26-2020
NIH NOT-HS-20-008 Notice of Intent: New Funding Opportunity Announcement to Support Novel, High-Impact Studies Evaluating Health System and Healthcare Professional Responsiveness to COVID-19  N/A 03-26-2020
Oak Ridge National Laboratory Rapid Access Proposal for COVID-19 Research Rolling 04-08-2020
Xsede  COVID-19 High Performance Computing Consortium Rolling 03-24-2020
U.S. Food and Drug Administration (FDA) FOR-FD-22-001 Innovation Grant: COVID-19 and Health Equity (R01) Clinical Trials Optional 03-31-2022 (Estimated) 06-15-2021
US Economic Development Administration EDA CARES Act Recovery Assistance
1. EDA CARES Act Overview Webinar Recording
2. EDA CARES Act Non-Competitive Awards Overview Webinar Recording
Rolling 05-07-2020
U.S. Food and Drug Administration (FDA)

NOT-FD-22-006 FDA Notice of Special Interest (NOSI) to add COVID-19 Capacity Building Grants to PAR-18-604 Vet-LIRN Network Capacity-Building Projects (Vet-LIRN)

Application Due Dates:
April 15, 2022, July 11, 2022 by 11:59PM Eastern Time.
April 15, 2023, July 10, 2023 by 11:59PM Eastern Time.

Various 02-07-2022